TrialJournal of clinical hypertension (Greenwich, Conn.)2007

A randomized, double-blind, placebo-controlled parallel-group study to assess the efficacy and safety of nebivolol, a novel beta-blocker, in patients with mild to moderate hypertension.

Robert J Weiss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.